Patents Assigned to MICROBIOME THERAPEUTICS LLC
  • Patent number: 10441602
    Abstract: A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: October 15, 2019
    Assignee: MicroBiome Therapeutics, LLC
    Inventors: Mark L. Heiman, Dean P. Stull, Justin W. Peno
  • Patent number: 9463169
    Abstract: A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: October 11, 2016
    Assignee: MicroBiome Therapeutics, LLC
    Inventors: Mark L. Heiman, Dean P. Stull, Justin W. Peno
  • Patent number: 9040101
    Abstract: Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure teaches compositions and methods for treating diabetes utilizing a gastrointestinal microbiome modulating composition.
    Type: Grant
    Filed: January 8, 2015
    Date of Patent: May 26, 2015
    Assignee: MicroBiome Therapeutics LLC.
    Inventors: Mark L. Heiman, Dean P. Stull, Justin W Peno
  • Publication number: 20150118330
    Abstract: Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure reaches compositions and methods for treating diabetes utilizing a gastrointestinal microbiome modulating composition.
    Type: Application
    Filed: January 8, 2015
    Publication date: April 30, 2015
    Applicant: MICROBIOME THERAPEUTICS LLC
    Inventors: Mark L. Heiman, Dean P. Stull, Justin W. Peno